Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity-Reference-Cited by-同舟云学术

Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity

Published:1986-12 Issue:4 Volume:13 Page:219-242
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Markman Maurie

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference257 articles.

1. Cisplatin in the treatment of advanced gastric carcinoma: A phase II study;Aabo;Cancer Treat. Rep.,1985

2. Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: A Gynecologic Oncology Group study;Abdulhay;Am. J. Obstet. Gynecol.,1985

3. Pharmacokinetics of mitomycin C following intraperitoneal administration of mitomycin C and floxuridine for peritoneal carcinomatosis;Adams,1984

4. In vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy;Alberts;Lancet,1980

5. In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration;Alberts;Semin. Oncol.,1985

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of neoadjuvant chemotherapy combined with intraperitoneal chemotherapy after interval tumor cell reduction on the prognosis of advanced epithelial ovarian cancer;European Journal of Gynaecological Oncology;2022

2. Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience;Journal of Gastrointestinal Oncology;2021-04

3. Intraperitoneal chemotherapy for ovarian cancer using sustained-release implantable devices;Expert Opinion on Drug Delivery;2018-03-06

4. Anticancer activity of the intraperitoneal-delivered DFP-10825, the cationic liposome-conjugated RNAi molecule targeting thymidylate synthase, on peritoneal disseminated ovarian cancer xenograft model;Drug Design, Development and Therapy;2018-03

5. Intraperitoneal chemotherapy against peritoneal carcinomatosis;Surgical Oncology;2014-06